Brucellosis Global Clinical Trials Review, H2, 2018

GlobalData's clinical trial report, “Brucellosis Global Clinical Trials Review, H2, 2018" provides an overview of Brucellosis clinical trials scenario. This report provides top line data relating to the clinical trials on Brucellosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

The Chanelle Group

Macleods Pharmaceuticals Ltd

SGS North America Inc

Emalex Biosciences LLC

Daiichi Sankyo Co Ltd

The Chanelle Group

Macleods Pharmaceuticals Ltd

SGS North America Inc

Emalex Biosciences LLC

Daiichi Sankyo Co Ltd

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region ...

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in Middle East and Africa 12

Clinical Trials by G7 Countries: Proportion of Brucellosis to Infectious Disease Clinical Trials 13

Clinical Trials by E7 Countries: Proportion of Brucellosis to Infectious Disease Clinical Trials 14

Clinical Trials by Phase 15

Clinical Trials by Trial Status 16

Clinical Trials by End Point Status 17

Subjects Recruited Over a Period of Time 18

Clinical Trials by Sponsor Type 19

Prominent Sponsors 20

Top Companies Participating in Brucellosis Therapeutics Clinical Trials 21

Prominent Drugs 22

Clinical Trial Profile Snapshots 23

Appendix 37

Abbreviations 37

Definitions 37

Research Methodology 38

Secondary Research 38

About GlobalData 39

Contact Us 39

Source 40

List of Tables

Brucellosis Therapeutics, Global, Clinical Trials by Region, 2018* 7

Brucellosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Brucellosis Therapeutics, Global ...

Brucellosis Therapeutics, Global, Clinical Trials by Region, 2018* 7

Brucellosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Brucellosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9

Brucellosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 10

Brucellosis Therapeutics Clinical Trials, Europe, Top Countries, 2018* 11

Brucellosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 12

Proportion of Brucellosis to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 13

Proportion of Brucellosis to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 14

Brucellosis Therapeutics, Global, Clinical Trials by Phase, 2018* 15

Brucellosis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 16

Brucellosis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 17

Brucellosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 18

Brucellosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 19

Brucellosis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 20

Brucellosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 21

Brucellosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 22

List of Figures

Brucellosis Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Brucellosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Brucellosis Therapeutics, Global ...

Brucellosis Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Brucellosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Brucellosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9

Brucellosis Therapeutics Clinical Trials, Europe, Top Countries (%), 2018* 11

Proportion of Brucellosis to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 13

Proportion of Brucellosis to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 14

Brucellosis Therapeutics, Global, Clinical Trials by Phase (%), 2018* 15

Brucellosis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 16

Brucellosis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 17

Brucellosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 18

Brucellosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 19

Brucellosis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 20

Brucellosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 21

Brucellosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 22

GlobalData Methodology 38

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports